Bo Spf15 | Avobenzone, Octinoxate Lotion while Breastfeeding

Q: If I am using Bo Spf15 | Avobenzone, Octinoxate Lotion , will my baby need extra monitoring?

Yes, Extra monitoring is required if mother is using Bo Spf15 | Avobenzone, Octinoxate Lotion and breastfeeding as it is considered unsafe for baby.

Bo Spf15 | Avobenzone, Octinoxate Lotion while Breastfeeding

Modern medicine has evolved so much so that sooner or later every breastfeeding mother needs to take it in one form or other. Medication that is present in mothers blood will transfer into her breast milk to some extent. Most drugs do so at low levels and pose no real risk to infants but then there are some exceptions. In This post will discuss whether Bo Spf15 | Avobenzone, Octinoxate Lotion is safe in breast-feeding or not.

What is Bo Spf15 | Avobenzone, Octinoxate Lotion used for?

Helps prevens sunburn If used as direced with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin again caused by the sun.

What are the risk associated with Bo Spf15 | Avobenzone, Octinoxate Lotion usage while breastfeeding? What precautions shall I take while using it in breastfeeding?

Bo Spf15 | Avobenzone, Octinoxate Lotion high risk while breastfeeding

Bo Spf15 | Avobenzone, Octinoxate Lotion consists two active ingredients Avobenzone and Octinoxate and as per our analysis of both we have determined the Bo Spf15 | Avobenzone, Octinoxate Lotion is unsafe during breastfeeding. We recommend you to check both ingredients below for better understanding of Bo Spf15 | Avobenzone, Octinoxate Lotion in breastfeeding.

Avobenzone and Breastfeeding

Safe

Not much study has been done on effects of topical usage of Avobenzone during breast feeding however it is known to penetrate the skin in very limited quantity. Its not very likely to have adverse effects in breastfed infants.

Note: Study and data for tropical use only, Breakdown product causes relatively high rates of skin allergy hence stabilization is required.

Warning: Tropical usage in breast area shall be avoided to prevent the Avobenzone passing orally in Infants.

Octinoxate and Breastfeeding

Unsafe

Octinoxate (Octylmethoxycinnamate) has been detected in human urine, blood and breast milk and is known for moderate risk of skin allergy. Some studies suggest that Octinoxate has estrogen like effects however less than 1% skin penetration has been found in human laboratory studies. As not much study has been done on effects of Octinoxate during breast feeding its recommended to use safe alternatives.

Octyl Methoxycinnamate (OMC) is a frequently used UV-filter in sunscreens and other cosmetics. Octinoxate can be systemically absorbed after skin application, being found in the deeper layers of the stratum corneum as well as urine, plasma, and breast milk. The mean maximum plasma concentration detected after application of 2mg/cm2 sunscreen was 7ng/mL in women and 16ng/mL in men. FDA study found blood levels 13 times above cutoff for systemic exposure.

Several studies indicated that OMC acts as an endocrine disruptor due to the ability to interfere with endocrine system at different levels. In humans OMC exposure has minor, but statistically significant effects on the levels of testosterone and estradiol. Moreover, some studies suggested that OMC can interact with the hypothalamo-pituitary-thyroid (HPT) axis.

Moreover, a study of offspring of dams treated with OMC (500�1000 mg/kg/day) showed sex-dependent behavioral changes, namely decreased motor activity in females, but not in males, and improved spatial learning in males, suggesting that OMC can affect neuronal development, however the doses used in these experiments were extremely high, not relevant to possible human exposure.

Note: Study and data for tropical use only

Warning: High dosage shall be avoided as reproductive system, thyroid and behavioral alterations in animal studies has been found, Tropical usage in breast area shall be avoided to prevent the OCTINOXATE passing orally in Infants.

I am nursing mother and I have already used Bo Spf15 | Avobenzone, Octinoxate Lotion, what should I do?

We have already established that Bo Spf15 | Avobenzone, Octinoxate Lotion is unsafe in breastfeeding and breastfeeding while using Bo Spf15 | Avobenzone, Octinoxate Lotion is not a good idea however if have already used and then breastfed the baby then you shall monitor the behavior and health of baby closely and inform your doctor as soon as possible. In case of emergency please call 911.

I am nursing mother and my doctor has suggested me to use Bo Spf15 | Avobenzone, Octinoxate Lotion, is it safe?

If your doctor knows that you are breastfeeding mother and still prescribes Bo Spf15 | Avobenzone, Octinoxate Lotion then there must be good reason for that as Bo Spf15 | Avobenzone, Octinoxate Lotion is considered unsafe, It usually happens when doctor finds that overall advantage of taking outweighs the overall risk.

If I am using Bo Spf15 | Avobenzone, Octinoxate Lotion, will my baby need extra monitoring?

Yes, Extra monitoring is required if mother is using Bo Spf15 | Avobenzone, Octinoxate Lotion and breastfeeding as it is considered unsafe for baby.

Who can I talk to if I have questions about usage of Bo Spf15 | Avobenzone, Octinoxate Lotion in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week